.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Federal Trade Commission
Citi
Boehringer Ingelheim
Fish and Richardson
Cerilliant
McKinsey
Medtronic
Teva
Baxter

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205532

« Back to Dashboard
NDA 205532 describes LITHIUM CARBONATE, which is a drug marketed by Hetero Labs Ltd Iii, Watson Labs, West-ward Pharms Int, Hikma Intl Pharms, Glenmark Generics, Mylan Pharms Inc, Able, Sun Pharm Inds Inc, Heritage Pharma, Pfizer, Usl Pharma, Glenmark Pharms Inc, Alembic Pharms Ltd, Alembic Ltd, Unique Pharm Labs, Barr, and Apotex Inc, and is included in twenty-nine NDAs. It is available from thirty-three suppliers. Additional details are available on the LITHIUM CARBONATE profile page.

The generic ingredient in LITHIUM CARBONATE is lithium carbonate. There are fifteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.

Summary for NDA: 205532

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Bipolar Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 205532

Suppliers and Packaging for NDA: 205532

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LITHIUM CARBONATE
lithium carbonate
TABLET, EXTENDED RELEASE;ORAL 205532 ANDA Heritage Pharmaceuticals Inc. 23155-293 23155-293-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (23155-293-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength300MG
Approval Date:Sep 29, 2016TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
US Army
Moodys
Farmers Insurance
Argus Health
Deloitte
US Department of Justice
Accenture
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot